SOLICITATION NOTICE
B -- Validation of Chemotherapy and Radiation Therapy Dose Information Found in Medicare Claims Data
- Notice Date
- 8/18/2006
- Notice Type
- Solicitation Notice
- NAICS
- 541990
— All Other Professional, Scientific, and Technical Services
- Contracting Office
- Department of Health and Human Services, National Institutes of Health, National Cancer Institute, Office of Acquisitions, 6120 Executive Blvd. EPS Suite 600, Rockville, MD, 20852
- ZIP Code
- 20852
- Solicitation Number
- Reference-Number-NCI-60157-NV
- Response Due
- 9/1/2006
- Archive Date
- 9/16/2006
- Description
- In accordance with simplified acquisition procedures the National Cancer Institute (NCI), Division of Cancer Control and Population Sciences (DCCPS), Applied Research Program (ARP), Health Services and Economics Branch (HSEB) plans to procure on a sole source basis with Regents of the University of Minnesota, 200 Oak St SE, Suite 450, Minneapolis, MN 55455 to validate chemotherapy and radiation therapy dose information found in Medicare claims data. Many researchers use Medicare data to study patterns of cancer care, particularly receipt of chemotherapy and radiation therapy. These modalities are of particular importance because they are used for initial therapy as well as for treating recurrences. Cancer-directed radiation provided in the first six months is collected by the Surveillance, Epidemiology, and End Results Program (SEER) cancer registries and has been successfully validated in Medicare claims, but radiation therapy provided after that time is not collected by SEER and has not been validated from Medicare sources. Researchers using Medicare data are often appropriately cautious about using Medicare data for such purposes but are also frustrated at the number of relevant questions that could be answered using Medicare if it could be shown that the data are an accurate reflection of clinical care. Using treatment information from the Cancer Care Outcomes Research and Surveillance Consortium (CanCORS) study medical record reviews and comparing it with information from Medicare claims data would allow for methods to be established to use Medicare data for in-depth study of chemotherapy and radiation therapy. Once validated, these methods could be used to assess subsequent treatment of CanCORS patients as well as patients identified via SEER/Medicare. This methodological work would demonstrate feasibility for future studies of cancer care using administrative data in combination with other sources. The objective of this study is to validate the use of Medicare claims for assessing radiation dosage, treatment delays and chemotherapy agent, along with dose, dose reduction and delay. The following questions will be answered: 1) What percentage of cases have information on radiotherapy (RT) use in both Medicare claims and charts?; 2) Do claims-based estimates of RT dose and duration, delays and complications match chart-based estimates?; 3) What percentage of cases have information on chemotherapy use in both Medicare claims and charts?; and 4) Do claims-based estimates of chemotherapy agent, dose and duration, delays, dose reductions and complications match chart-based estimates? In addition, this project will provide technical assistance to the CanCORS Statistical Coordinating Center (SCC) to support the process of linking CanCORS and Medicare data and provide technical assistance to other researchers using linked CanCORS/Medicare data. This assistance will be in the form of direct consultation and through managing the CanCORS Medicare linkage working group. The University of Minnesota School of Public Health with Dr. Beth Virnig, Ph.D., M.P.H. have the unique experience and background that combines understanding of methodologies appropriate for validating administrative/claims data against other information sources and knowledge of the CanCORS project. With twelve years of experience using Medicare data they are nationally-recognized as Medicare data experts. They are a member of the CanCORS consortium, and Dr. Virnig was a member of the committee that designed the Medical Record Review Instrument. The combination of Medicare expertise and CanCORS knowledge is unique and essential for carrying out the objectives described in this SOW. This is the only known source to the NCI researcher that has the access to the data and the expertise to complete this validation. This is not a solicitation for competitive quotations. However, if any interested party believes it can meet the entire above requirement, they may submit a statement of capabilities. All information furnished shall be in writing and must contain sufficient detail to allow the NCI researcher to determine if it can meet the requirements of this synopsis. An original and one copy of the capability statements must be received in the Contracting Office by 1PM EDT (local Washington, D.C. time) on September 1, 2006. Faxed and emailed capability statements are NOT authorized. All questions must be in writing and may be emailed to Debbie Moore at dm170b@nih.gov or faxed (301) 402-4513. It is the vendor?s responsibility to call (301) 402-4509 and verify that questions were received. In order to receive an award from the NCI contractors must be registered in the Online Representations and Certifications Applications (ORCA). Please refer to http://orca.bpn.gov in order to register. In addition, contractors must be registered in the Central Contractor Registration (CCR) www.ccr.gov. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. No collect calls will be accepted. NAICS: 541990; Size Standard is 6 million
- Record
- SN01119198-W 20060820/060818220546 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |